Oncology Central

Protein-cased biomarker blood test improves assessment of lung cancer risk in smokers

Lung cancer risk assessment could be improved over existing guidelines by a four-protein biomarker blood test, an international research team has reported in JAMA Oncology. So far, the test has been effective in capturing risks in individuals who would not be described as heavy smokers, and for those who may not have been a smoker for a long time.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.